Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Hematology|September 11, 2023
Factor XI as a therapeutic target in neuroinflammatory diseaseBerk Taskin, Tia C L Kohs, Joseph J Shatzel, et al.
Cellular and Molecular Bioengineering|January 20, 2023
The Applications and Challenges of the Development of In Vitro Tumor Microenvironment ChipsAnnika Johnson, Samuel Reimer, Ryan Childres, et al.
Seminars in Thrombosis and Hemostasis|March 20, 2023
Substrates, Cofactors, and Cellular Targets of Coagulation Factor XIaAndré L Lira, Tia C L Kohs, Samantha A Moellmer, et al.
American Journal of Physiology. Cell Physiology|November 13, 2023
Cytoprotective E-WE thrombin reduces disease severity in a murine model of relapsing-remitting multiple sclerosisNorah G Verbout, Weiping Su, Peter Pham, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 2, 2021
Heparin Resistance Is Common in Patients Undergoing Extracorporeal Membrane Oxygenation but Is Not Associated with Worse Clinical OutcomesVikram Raghunathan, Patricia Liu, Tia C L Kohs, et al.
Platelets|August 6, 2021
Severe thrombocytopenia in adults undergoing extracorporeal membrane oxygenation is predictive of thrombosisTia C L Kohs, Patricia Liu, Vikram Raghunathan, et al.
Cellular and Molecular Bioengineering|July 17, 2023
Correction: Innovation and Entrepreneurship in Promotion and Tenure in Biomedical EngineeringTia C L Kohs, Samuel N Clarin, Rich G Carter, et al.
European Journal of Haematology|February 2, 2021
CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real-world practiceMalinda T West, Claire E Smith, Andy Kaempf, et al.
Journal of Thrombosis and Thrombolysis|December 14, 2023
Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registryTia C L Kohs, Benjamin R Weeder, Boris I Chobrutskiy, et al.
Cellular and Molecular Bioengineering|July 17, 2023
Innovation and Entrepreneurship in Promotion and Tenure in Biomedical Engineering: Communication from the Biomedical Engineering Society Long Range Planning CommitteeTia C L Kohs, Samuel N Clarin, Rich G Carter, et al.
Pageof 2